bpMedManage: Digital Technology to Support Adherence to Hypertension Medications
Digital Technology to Support Adherence to Hypertension Medications for Older Adults With Mild Cognitive Impairment
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 60 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This 16-week study tests whether smartphone reminders help older adults with mild memory or thinking problems take their blood pressure medicine. One group gets medicine reminders and health lessons on a smartphone. The other group gets only the health lessons.
The purpose of the bpMedManage study is to rigorously test the efficacy of a smartphone technology to help improve high blood pressure medication adherence among older adults with mild cognitive impairment (MCI) in a 16-week randomized controlled trial. A total of 100 older adults will be recruited. There will be two treatment arms, bpMedManage-S and bpMedManage-P with 50 participants in each arm. Participants randomized into the bpMEDManage-S intervention arm will use a smartphone application with medication reminders plus receive education with standardized information on hypertension and antihypertensive medications on the education portal. Participants in the bpMedManage-P group will use a smartphone to receive education with standardized information on hypertension and antihypertensive medications on an education portal. Both groups will complete baseline assessments followed by 4 weeks of medication adherence monitoring. At the end of the adherence monitoring period, participants will be randomized into one of the two treatment arms. Immediate outcomes on primary and secondary measures will be assessed 4 weeks after beginning of the intervention. Follow-up outcomes will be assessed 12 weeks after the beginning of the intervention.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Age 60 or older and living in the community.
- Say you speak English fluently and can see and hear well enough.
- Report problems with memory, thinking, or focus.
- Manage at least one prescribed blood pressure medicine on your own.
- Have and use a smartphone.
- Report no history of major depression or other mental health diagnoses.
- Report no diagnosis of dementia or other brain or nerve disorders, such as stroke, traumatic brain injury, or Parkinson’s disease.
- Score 27–37 on the TICS-M and 20–26 on the MoCA, two memory and thinking tests, and agree to take part for at least 4 months.
Who can't join
- Have a diagnosis of dementia, a condition that affects memory and thinking.
- Live in an assisted living facility or skilled nursing facility.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: 1. Age 60+ 2. Community-dwelling older adults 3. Self-reported fluent in English 4. Adequate self-reported visual and hearing ability 5. Self-reported memory, thinking, or concentration challenges 6. Self-manage at least one prescribed antihypertensive medication 7. Have and use a smartphone 8. No self-reported history of major depression or other mental health diagnoses 9. No self-reported diagnosis of dementia or other neurological disorder such as stroke, TBI, and Parkinson's disease 10. TICS-M score between 27-37 and Montreal Cognitive Assessment (MoCA) score between 20-26 11. Willing to participate in the study for at least 4 months Exclusion Criteria: 1. Diagnosis of dementia 2. Lives in assisted living facility or skilled nursing facility
Study sites (2)
AZ
- University of Arizona · Tucson, AZ 85721Kathleen Insel, PhD · Study contact · 520-626-6220 · insel@arizona.eduMore trials in Tucson
IL
- University of Illinois, Urbana-Champaign · Champaign, IL 61820Raksha Mudar, PhD · Study contact · 217-333-4718 · raksha@illinois.eduMore trials in Champaign